{"id":"W1976411264","doi":"10.1159/000354085","title":"Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)","year":2013,"lang":"en","type":"article","venue":"Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Sanofi","keywords":"Gemcitabine; Cisplatin; Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Bladder cancer; Urology; Oncology; Confidence interval; Metastatic Urothelial Carcinoma; Phases of clinical research; Randomized controlled trial; Chemotherapy; Cancer; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002621402,0.001470071,0.002605354,0.0005094393,0.0004038161,0.001285234,0.0009833323,0.001639341,0.00622169],"category_scores_gemma":[0.00196491,0.0004481466,0.00179891,0.000522831,0.001366779,0.00122122,0.0005043133,0.003334331,0.0008944367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001152756,"about_ca_system_score_gemma":0.002605936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001164158,"about_ca_topic_score_gemma":0.002903997,"domain_scores_codex":[0.999244,0.0004553556,0.00003936556,0.0001173518,0.00005503622,0.00008900486],"domain_scores_gemma":[0.9986622,0.0003506272,0.0003388963,0.00006503476,0.00006660725,0.0005166371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9526638,0.007381042,0.0009732249,0.001393764,0.0007613961,0.00006656451,0.0000845735,0.0005139697,0.003594875,0.0002146316,0.002186464,0.03016577],"study_design_scores_gemma":[0.9442245,0.05310538,0.0007613744,0.00005090726,0.0002795378,0.00005450027,0.0000145656,0.0002917951,0.0004091107,0.00008076934,0.0007171296,0.0000102953],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755498,0.01243988,0.0007891533,0.001682968,0.0006058275,0.005139626,0.001083314,0.0002322564,0.002477261],"genre_scores_gemma":[0.975269,0.006121071,0.003194091,0.002276485,0.0005383099,0.007829042,0.001813462,0.00005019148,0.002908225],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00622169,"threshold_uncertainty_score":0.02081358,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0321201909268654,"score_gpt":0.3576284512148955,"score_spread":0.3255082602880301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}